Goldman Sachs Knock-Out VWSB/ DE000GK2RMH9 /
2024-05-20 9:01:35 AM | Chg.-0.04 | Bid1:41:29 PM | Ask1:41:29 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.12EUR | -3.45% | 1.11 Bid Size: 50,000 |
1.12 Ask Size: 50,000 |
VESTAS WIND SYS. DK ... | 108.5496 - | 2078-12-31 | Call |
GlobeNewswire
2:20 PM
Gray Television Commences Cash Tender Offer for Its 5.875% Senior Notes Due 2026
GlobeNewswire
2:10 PM
Launch Your Merch FREE 4-Day Challenge Empowers Entrepreneurs to Build Profitable Merch Stores Onlin...
GlobeNewswire
2:05 PM
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
GlobeNewswire
2:05 PM
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Diseas...
GlobeNewswire
2:01 PM
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Pric...
GlobeNewswire
2:01 PM
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation ...
GlobeNewswire
2:01 PM
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...
GlobeNewswire
2:00 PM
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Perio...
GlobeNewswire
2:00 PM
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
GlobeNewswire
2:00 PM
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Tes...
GlobeNewswire
2:00 PM
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO ...
GlobeNewswire
2:00 PM
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire
2:00 PM
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile...
GlobeNewswire
2:00 PM
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
GlobeNewswire
2:00 PM
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foo...
GlobeNewswire
2:00 PM
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)